Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
Relevance. The vaccine against the SARS-Cov-2 coronavirus is considered as the most promising approach to curb (tame) a current pandemic and prevent new one. Three vaccines (AstraZeneca’s СhAdOx1 nCov-19, CanSino’s vaccine and Russia’s Sputnik V one) are in Phase III clinical trials and have the S p...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Numikom LLC
2020-11-01
|
Series: | Эпидемиология и вакцинопрофилактика |
Subjects: | |
Online Access: | https://www.epidemvac.ru/jour/article/view/1080 |